Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J De Bree

Showing results (161-170 of 174) with videos related to

Pageof 18
Sort By:
Frontiers in Immunology|January 7, 2022
Implementation of Early Next-Generation Sequencing for Inborn Errors of Immunity: A Prospective Observational Cohort Study of Diagnostic Yield and Clinical Implications in Dutch Genome Diagnostic CentersKim Elsink, Manon M H Huibers, Iris H I M Hollink, et al.
Elife|November 23, 2021
Cross-reactive antibodies after SARS-CoV-2 infection and vaccinationMarloes Grobben, Karlijn van der Straten, Philip Jm Brouwer, et al.
Nature Communications|August 4, 2022
A public antibody class recognizes an S2 epitope exposed on open conformations of SARS-CoV-2 spikeMathieu Claireaux, Tom G Caniels, Marlon de Gast, et al.
STAR Protocols|March 15, 2021
<i>In vitro</i> induction of trained immunity in adherent human monocytesJorge Domínguez-Andrés, Rob J W Arts, Siroon Bekkering, et al.
Science (New York, N.Y.)|June 17, 2020
Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerabilityPhilip J M Brouwer, Tom G Caniels, Karlijn van der Straten, et al.
The Lancet. Microbe|October 5, 2020
Viral presence and immunopathology in patients with lethal COVID-19: a prospective autopsy cohort studyBernadette Schurink, Eva Roos, Teodora Radonic, et al.
Journal of Clinical Immunology|August 25, 2025
Self-reported Clinical Outcomes and Quality of Life in Agammaglobulinemia: the Importance of an Early DiagnosisMaartje Blom, Annelotte J Duintjer, Mahnaz Jamee, et al.
Science Translational Medicine|May 12, 2021
High titers and low fucosylation of early human anti-SARS-CoV-2 IgG promote inflammation by alveolar macrophagesWillianne Hoepel, Hung-Jen Chen, Chiara E Geyer, et al.
Research Square|February 23, 2021
COVA1-18 neutralizing antibody protects against SARS-CoV-2 in three preclinical modelsP Maisonnasse, Y Aldon, A Marc, et al.
Nature Communications|November 21, 2025
HIV-1 envelope trimer vaccine induces sex-associated differences in antibody responses: a phase 1 clinical trialEmma I M M Reiss, Karlijn van der Straten, Laura T M Graus, et al.
Pageof 18

Showing results (161-170 of 174) with videos related to

Sort By:
Pageof 18
Frontiers in Immunology|January 7, 2022
Implementation of Early Next-Generation Sequencing for Inborn Errors of Immunity: A Prospective Observational Cohort Study of Diagnostic Yield and Clinical Implications in Dutch Genome Diagnostic CentersKim Elsink, Manon M H Huibers, Iris H I M Hollink, et al.
Elife|November 23, 2021
Cross-reactive antibodies after SARS-CoV-2 infection and vaccinationMarloes Grobben, Karlijn van der Straten, Philip Jm Brouwer, et al.
Nature Communications|August 4, 2022
A public antibody class recognizes an S2 epitope exposed on open conformations of SARS-CoV-2 spikeMathieu Claireaux, Tom G Caniels, Marlon de Gast, et al.
STAR Protocols|March 15, 2021
<i>In vitro</i> induction of trained immunity in adherent human monocytesJorge Domínguez-Andrés, Rob J W Arts, Siroon Bekkering, et al.
Science (New York, N.Y.)|June 17, 2020
Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerabilityPhilip J M Brouwer, Tom G Caniels, Karlijn van der Straten, et al.
The Lancet. Microbe|October 5, 2020
Viral presence and immunopathology in patients with lethal COVID-19: a prospective autopsy cohort studyBernadette Schurink, Eva Roos, Teodora Radonic, et al.
Journal of Clinical Immunology|August 25, 2025
Self-reported Clinical Outcomes and Quality of Life in Agammaglobulinemia: the Importance of an Early DiagnosisMaartje Blom, Annelotte J Duintjer, Mahnaz Jamee, et al.
Science Translational Medicine|May 12, 2021
High titers and low fucosylation of early human anti-SARS-CoV-2 IgG promote inflammation by alveolar macrophagesWillianne Hoepel, Hung-Jen Chen, Chiara E Geyer, et al.
Research Square|February 23, 2021
COVA1-18 neutralizing antibody protects against SARS-CoV-2 in three preclinical modelsP Maisonnasse, Y Aldon, A Marc, et al.
Nature Communications|November 21, 2025
HIV-1 envelope trimer vaccine induces sex-associated differences in antibody responses: a phase 1 clinical trialEmma I M M Reiss, Karlijn van der Straten, Laura T M Graus, et al.
Pageof 18